MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer

This study has been terminated.

(This Phase I study was permanently closed to patient accrual on February 23, 2011, due to the discontinuation of support from MERCK.)

Sponsor:

Collaborator:

Information provided by (Responsible Party):

Pediatric Brain Tumor Consortium

ClinicalTrials.gov Identifier:

NCT00572182

First received: December 11, 2007

Last updated: March 2, 2012

Last verified: March 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	February 2011
Primary Completion Date:	February 2011 (Final data collection date for primary outcome measure)